SUN PHARMA ADVANCED RESEARCH COMPANY LTD. Q4 FY26 Results
SPARCQ4 FY26 ResultsAnnounced 18 May, 8:41 pm| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 1.9K | 21831.6% | 6715.8% |
| Total Income | 1.9K | 21852.9% | 6722.4% |
| Expenditure | 94.06 | 23.1% | 7.1% |
| PBT | 1.8K | 2291.6% | 3002.5% |
| Net Profit | 1.8K | 2290.2% | 3046.9% |
| OPM | 95.68% | ||
| NPM | 94.95% | ||
| EPS | 54.27 | 2088.3% | 2849.5% |
Informational and educational content only. Not investment advice.